ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The “Help Ricky Heal” Initiative Shares a Brave Boy’s Journey Through Unimaginable Challenges and the Hope that Lies Ahead

By: Get News
Supporters are banding together to raise money for Ricky, a young boy living with chronic graft-versus-host disease (GVHD)

A young boy named Ricky is turning heads and touching hearts as he shares his resilient battle with GVHD, or chronic graft-versus-host disease. Since infancy, he has faced rare diseases, life-threatening complications, and years of painful treatments, but through it all, Ricky’s strength and spirit have continued to shine.

When he was just 8 months old, Ricky was diagnosed with Juvenile Xanthogranuloma (JXG). This disease required four years of chemotherapy, and at age five, a near-drowning accident led to him being placed in a medically induced coma for one month. When Ricky was 10 years old, he was diagnosed with Acute Lymphoblastic Leukemia (ALL) - a devastating blow that ushered in a new wave of aggressive treatments. Ricky then endured CAR-T cell therapy, full-body radiation twice daily for three days, and a bone marrow transplant from his father - a procedure that saved his life, but at a cost. The transplant led to chronic graft-versus-host disease, or GVHD.

GVHD is a rare and debilitating disease in which the body’s immune system attacks the host’s tissues. Now, Ricky is wheelchair-bound and suffers from severe joint damage, chronic pain, muscle atrophy and persistent inflammation. Ricky’s case is complex and considered among the most challenging at Children’s Hospital of Orange County. Despite the best efforts of his healthcare team, the doctors aren’t sure why Ricky’s condition continues to deteriorate - and they no longer have a clear path forward.

Ricky’s family connected with Forgotten Formula PMA, a community of doctors and clinics focused on addressing the root causes of chronic illnesses. Founder Michael Blake personally took on Ricky’s case and connected his family with Dr. Kent Holtorf and Dr. Mortenson to create a personalized treatment with IV mesenchymal stem cell (MSC) therapy at the core. MSC therapy leverages the regenerative properties of stem cells to repair damaged tissues, reduce inflammation, and restore immune balance. Ricky’s doctors believe this therapy could reverse the effects of GVHD, reduce his pain, and potentially restore his mobility.

Ricky’s personalized treatment also includes adjunct treatment such as exosome therapy for promoting cellular repair and healing; peptide therapy for tissue regeneration and immune function; hyperbaric oxygen therapy, plasmapharesis for filtering inflammatory cells out of the blood; physical therapy; and specialized nutritional support.

While all of this is promising, the financial aspect of it all is a major blow for Ricky’s family. The estimated cost for the full course of treatment, including all therapies and ongoing care, is $150,000. Ricky’s family is reaching out to our community of friends, family, and supporters to help raise $150,000 so Ricky can begin this potentially life-changing treatment as soon as possible. Every contribution—large or small—will go directly toward Ricky’s care.

Donors from around the country have already stepped up to help provide treatment for Ricky, a vibrant, kind young boy who only wants to walk again and live without pain. Ricky’s story is a reminder of what’s possible when people come together in support of something bigger than themselves.

Learn more and donate now by visiting http://spot.fund/1ztdmwqsq or by scanning the QR code below.

Media Contact
Contact Person: Richard Alcedo
Email: Send Email
Country: United States
Website: http://spot.fund/1ztdmwqsq

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.